Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garnet Suck

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Seminars in Cancer Biology|August 18, 2006
Novel approaches using natural killer cells in cancer therapyGarnet Suck
Hematology/Oncology and Stem Cell Therapy|October 5, 2010
Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectorsGarnet Suck, Mickey Boon Chai Koh
Biologicals : Journal of the International Association of Biological Standardization|March 13, 2012
Cell therapy: promise fulfilled?Mickey B C Koh, Garnet Suck
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 27, 2016
Natural Killer Cells for Therapy of LeukemiaGarnet Suck, Yeh Ching Linn, Torsten Tonn
Journal of Virology|August 17, 2004
Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expressionJohn Nicewonger, Garnet Suck, Donald Bloch, et al.
International Immunology|July 20, 2006
Constitutively polarized granules prime KHYG-1 NK cellsGarnet Suck, Donald R Branch, Paola Aravena, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 14, 2021
Transregional autologous serum eye drop provision by a large German Red Cross Blood Donation ServiceGarnet Suck, Javier Antonio Noriega Urena, Andreas Grolle, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2015
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapyGarnet Suck, Marcus Odendahl, Paulina Nowakowska, et al.
Experimental Hematology|October 13, 2005
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicityGarnet Suck, Donald R Branch, Mark J Smyth, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2016
Selection and expansion of natural killer cells for NK cell-based immunotherapyPetra S A Becker, Garnet Suck, Paulina Nowakowska, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|August 18, 2006
Novel approaches using natural killer cells in cancer therapyGarnet Suck
Hematology/Oncology and Stem Cell Therapy|October 5, 2010
Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectorsGarnet Suck, Mickey Boon Chai Koh
Biologicals : Journal of the International Association of Biological Standardization|March 13, 2012
Cell therapy: promise fulfilled?Mickey B C Koh, Garnet Suck
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 27, 2016
Natural Killer Cells for Therapy of LeukemiaGarnet Suck, Yeh Ching Linn, Torsten Tonn
Journal of Virology|August 17, 2004
Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expressionJohn Nicewonger, Garnet Suck, Donald Bloch, et al.
International Immunology|July 20, 2006
Constitutively polarized granules prime KHYG-1 NK cellsGarnet Suck, Donald R Branch, Paola Aravena, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 14, 2021
Transregional autologous serum eye drop provision by a large German Red Cross Blood Donation ServiceGarnet Suck, Javier Antonio Noriega Urena, Andreas Grolle, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2015
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapyGarnet Suck, Marcus Odendahl, Paulina Nowakowska, et al.
Experimental Hematology|October 13, 2005
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicityGarnet Suck, Donald R Branch, Mark J Smyth, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2016
Selection and expansion of natural killer cells for NK cell-based immunotherapyPetra S A Becker, Garnet Suck, Paulina Nowakowska, et al.
Pageof 2